Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib

Clinical trial NCT02056080 · COMPLETED

Trial details

NCT number: NCT02056080
Sponsor: MedSIR
Status: COMPLETED
Study type: OBSERVATIONAL

Breast Neoplasm

Start date: 2013-01-01
Primary completion: 2014-01-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.